World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01948687
Date of registration: 03/09/2013
Prospective Registration: No
Primary sponsor: University of Medicine and Pharmacy Craiova
Public title: Real Time Elastography in Liver Fibrosis RT-ELASTO
Scientific title: The Role of Real Time Elastography in the Noninvasive Assessment of Liver Fibrosis in Chronic Viral Hepatitis
Date of first enrolment: August 2013
Target sample size: 500
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01948687
Study type:  Observational
Study design:  Observational Model: Case-Only, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Romania
Contacts
Name:     Larisa D Sandulescu, MD, PhD
Address: 
Telephone: +40723968354
Email: larisasandulescu@yahoo.com
Affiliation: 
Name:     Adrian Saftoiu, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  UMF Craiova
Key inclusion & exclusion criteria

Inclusion Criteria:

- age over 18 years old

- Study will include three groups of patients as follows:

1. Group I: patients with chronic hepatitis B or C (defined by the presence
of serum anti HCV antibody or serum hepatitis B surface antibody)

2. Group II (the control group): healthy adult volunteers

3. Group III: patients with hepatic cirrhosis type B or C

- There at least one reference method available for patients with chronic hepatitis
(Transient elastography/ liver biopsy)

- Hepatic cirrhosis diagnosis is established using clinical and paraclinical features
(ultrasonography, superior digestive endoscopy)

- A written informed consent is given to each patient

Exclusion Criteria:

- Patients with contraindication for elastography (pregnant women or who are
breastfeeding) and patients with pacemakers

- Patients with liver disease of other etiology than viral infection (autoimmune
hepatitis, primary biliary hepatitis, primary sclerosing cholangitis,
hemochromatosis, alfa 1-antitrypsin deficiency, or Wilson's disease)

- History of alcohol abuse (alcohol intake> 20g/day)

- Patients under treatment with hepatotoxic drugs (methotrexate, amiodarone,
corticotherapy , chemotherapy, hormonotherapy)

- Patients with technically unfeasible TE: patients with ascites



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Chronic Liver Disease
Cirrhosis
Intervention(s)
Primary Outcome(s)
Real Time Elastography result [Time Frame: up to 24 weeks]
Secondary Outcome(s)
Secondary ID(s)
RT-ELASTO
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history